Capital Investment Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Capital Investment Advisory Services's NVO Position: Q2 2026 in Review
Capital Investment Advisory Services increased its Novo Nordisk (NVO) stake by 11% in Q2 2026, buying an estimated $52.4K and bringing the position to 12,314 shares worth $590K. The position accounts for 0.04% of the portfolio, ranked #414.
Capital Investment Advisory Services first reported a position in NVO in Q4 2018 and has held it in 19 quarters since. The position peaked at $1.13M in Q3 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Capital Investment Advisory Services held 12,314 shares of Novo Nordisk worth $590K as of Q2 2026.
- Capital Investment Advisory Services bought 1,219 Novo Nordisk shares in Q2 2026, an estimated $52.4K.
- Novo Nordisk made up 0.04% of Capital Investment Advisory Services's portfolio in Q2 2026, its #414 holding.
- Capital Investment Advisory Services first reported a position in Novo Nordisk in Q4 2018 and has held it in 19 quarters since.
- Capital Investment Advisory Services's Novo Nordisk position peaked at $1.13M in Q3 2024.
- 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.